Cresco Labs (CRLBF) Capital Leases (2023 - 2026)
Cresco Labs (CRLBF) reported Capital Leases of $17.6 million for Q1 2026, down 3.91% quarter-over-quarter from $18.3 million in Q4 2025.
Cresco Labs (CRLBF) Capital Leases (2023 - 2026) Analysis & Trends
Cresco Labs has reported Capital Leases for 3 years, with the latest figure at $17.6 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases changed N/A year-over-year to $17.6 million; the trailing twelve-month figure through Mar 2026 stood at $17.6 million (changed N/A YoY), and the FY2025 full-year result was $18.3 million, changed N/A from the prior year.
- Capital Leases for Q1 2026 stood at $17.6 million, down from $18.3 million in the prior quarter.
- The five-year high for Capital Leases was $22.4 million in Q4 2023, with the low at $17.6 million in Q1 2026.
- Historically, Capital Leases has averaged $19.4 million across 3 years, with a median of $18.3 million in 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.56 Mn |
| Dec 31, 2025 | 18.27 Mn |
| Dec 31, 2023 | 22.38 Mn |